J&J Enters LAA Closure Market In Earnest With Coherex Buy

This article was originally published in The Gray Sheet

20 Nov 2015
News

Executive Summary

J&J's Biosense Webster heart-rhythm device unit has acquired privately held partner Coherex Medical, solidifying its stake in the left atrial appendage closure market that Boston Scientific currently leads.

Already Registered? Sign in to continue reading.

New to Medtech Insight? Start a free trial today!

Table
View full table

Topics

Related Companies

Related Deals

Biosense Webster buys fellow cardio device maker Coherex

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Medical Device Europe Strategy

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

MT034400

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

MT034400

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

J&J Enters LAA Closure Market In Earnest With Coherex Buy

News

Executive Summary

Related Content

Who's Next? Emerging LAA Closure Devices

Topics

Related Companies

Related Deals

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert